Application of multiple regression analysis in optimization of anastrozole-loaded PLGA nanoparticles

References

• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev, 2006;58:1688–713
   PubMed Web of Science ®Google Scholar
• Acharya S, Dilnawaz F, Sahoo SK. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials, 2009;30:5737–50
   PubMed Web of Science ®Google Scholar
• Adinarayana K, Ellaiah P. Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J Pharm Pharm Sci, 2002;5:272–8
   PubMed Web of Science ®Google Scholar
• Ahlin P, Kristl J, Kristl A, Vrecer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int J Pharm, 2002;239:113–20
   PubMed Web of Science ®Google Scholar
• Akhnazarova S, Kafarov V. 1982. Experiment optimization in chemistry and chemical engineering. Moscow: Mir Publications
   Google Scholar
• Armstrong AN, James KC. 1996. Pharmaceutical experimental design and interpretation. Bristol, USA: Taylor and Francis Publishers
   Google Scholar
• Bolton S, Bon C. 1997. Pharmaceutical statistics: Practical and clinical applications, 3rd edn. New York: Marcel Dekker Inc
   Google Scholar
• Box GEP, Hunter WG, Hunter JS. 1978. Statistics for experiments. New York: John Wiley and Sons
   Google Scholar
• Box GEP, Wilson KB. On the experimental attainment of optimum conditions. J Roy Stat Soc, 1951;13:1–45
   Google Scholar
• Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(d,l lactide-glycolide) carriers. Eur J Pharm Sci, 1999;8:99–107
   PubMed Web of Science ®Google Scholar
• Chaudhari KR, Shah N, Patel H, Murthy R. Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: Bleomycin sulphate. J Microencapsul, 2010;27:303–13
   PubMed Web of Science ®Google Scholar
• Chowdhury S, Ellis PA. Recent advances in the use of aromatase inhibitors for women with postmenopausal breast cancer. J Br Menopause Soc, 2005;11:96–102
   PubMedGoogle Scholar
• Corrigan OI, Li X. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci, 2009;37:477–85
   PubMed Web of Science ®Google Scholar
• Das M, Sahoo SK. Folate decorated dual drug loaded nanoparticle: Role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance. PLoS One, 2012;7:e32920
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomed, 2008;3:133–49
   PubMed Web of Science ®Google Scholar
• Derringer G, Suich R. Simultaneous optimization of several response variables. J Quality Technol, 1980;12:214–19
   Web of Science ®Google Scholar
• Dubernet C. Thermoanalysis of microspheres. Thermochim Acta, 1995;248:259–69
   Web of Science ®Google Scholar
• Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53–69
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm, 1989;55:R1–4
   Web of Science ®Google Scholar
• Jain NK, Ram A. Development and characterization of nanostructured lipid carriers of oral hypoglycemic agent: Selection of surfactants. Int J Pharm Sci Rev Res, 2011;7:125–30
   Google Scholar
• Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm, 2010;76:189–99
   PubMed Web of Science ®Google Scholar
• Kashi TS, Eskandarion S, Esfandyari-Manesh M, Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomed, 2012;7:221–34
   PubMed Web of Science ®Google Scholar
• Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Coll Surf A: Physicochem Eng Aspect, 2001;182:123–30
   Web of Science ®Google Scholar
• Lacoulonche F, Gamisans F, Chauvet A, Garcia ML, Espina M, Egea MA. Stability and in vitro drug release of flurbiprofen-loaded poly-epsilon-caprolactone nanospheres. Drug Dev Ind Pharm, 1999;25:983–93
   PubMed Web of Science ®Google Scholar
• Levison KK, Takayama K, Isowa K, Okabe K, Nagai T. Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci, 1994;83:1367–72
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. Praziquantel-loaded PLGA nanoparticles: Preparation and characterization. J Microencapsul, 2005;22:13–24
   PubMed Web of Science ®Google Scholar
• Mak KWY, Yap MGS, Teo WK. Formulation and optimization of two culture media for the production of tumour necrosis factor-β in Escherichia coli. J Chem Tech Biotechnol, 1995;62:289–94
   Web of Science ®Google Scholar
• Mendes GD, Hamamoto D, Ilha J, Pereira Ados S, De Nucci G. Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies. J Chromatograph, 2007;850:553–9
   Web of Science ®Google Scholar
• Miller AJ. Selection of subsets of regression variables. J R Stat Soc Ser A, 1984;147:389–425
   Web of Science ®Google Scholar
• Misra R, Sahoo SK. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Eur J Pharm Sci, 2010;39:152–63
   PubMed Web of Science ®Google Scholar
• Montgomery DC. 2004. Introduction to factorial designs. New York: John Wiley and Sons
   Google Scholar
• Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm, 2006;325:172–9
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Manjappa AS, Murthy RSR, Pol YD. A novel pH-triggered in situ gel for sustained ophthalmic delivery of ketorolac tromethamine. Asian J Pharm Sci, 2009;4:189–99
   Google Scholar
• Paolicelli P, Prego C, Sanchez A, Alonso MJ. Surface-modified PLGA-based nanoparticles that can efficiently associate and deliver virus-like particles. Nanomedicine, 2010;5:843–53
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60:110–11
   PubMedGoogle Scholar
• Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: In vitro characterisation and in vivo evaluation. J Control Release, 2001;70:353–63
   PubMed Web of Science ®Google Scholar
• Sarkar K, Yang H. Encapsulation and extended release of anti-cancer anastrozole by stealth nanoparticles. Drug Deliv, 2008;15:343–6
   PubMed Web of Science ®Google Scholar
• Schulz WA. 2005. Molecular biology of human cancers: An advanced student's textbook. USA: Springer
   Google Scholar
• Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomater, 2011;7:4169–76
   PubMed Web of Science ®Google Scholar
• Shah N, Chaudhari K, Dantuluri P, Murthy RS, Das S. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target, 2009;17:533–42
   PubMed Web of Science ®Google Scholar
• Shi K, Cui F, Yamamoto H, Kawashima Y. Optimized formulation of high-payload PLGA nanoparticles containing insulin-lauryl sulfate complex. Drug Dev Ind Pharm, 2009;35:177–84
   PubMed Web of Science ®Google Scholar
• Shirakura O, Yamada M, Hashimoto M, Ishimaru S, Takayama K, Nagai T. Particle-size design using computer optimization technique. Drug Dev Ind Pharm, 1991;17:471–83
   Web of Science ®Google Scholar
• Snehalatha M, Venugopal K, Saha RN, Babbar AK, Sharma RK. Etoposide loaded PLGA and PCL nanoparticles II: Biodistribution and pharmacokinetics after radiolabeling with Tc-99m. Drug Deliv, 2008;15:277–87
   PubMed Web of Science ®Google Scholar
• Thode K, Muller RH, Kresse M. Two-time window and multiangle photon correlation spectroscopy size and zeta potential analysis–highly sensitive rapid assay for dispersion stability. J Pharm Sci, 2000;89:1317–24
   PubMed Web of Science ®Google Scholar
• Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. Diclofenac sodium incorporated PLGA (50:50) microspheres: Formulation considerations and in vitro/in vivo evaluation. Int J Pharm, 2000;195:179–88
   PubMed Web of Science ®Google Scholar
• Wagner JM, Shimshak DG. Stepwise selection of variables in data envelopment analysis: Procedures and managerial perspectives. Eur J Oper Res, 2007;180:57–67
   Web of Science ®Google Scholar
• Yadav KS, Sawant KK. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. Aaps Pharmscitech, 2010;11:1456–65
   PubMed Web of Science ®Google Scholar
• Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release, 1999;59:299–307
   PubMed Web of Science ®Google Scholar
• Yee L, Blanch HW. Defined media optimization for growth of recombinant Escherichia coli X90. Biotechnol Bioeng, 1993;41:221–30
   PubMed Web of Science ®Google Scholar